152 related articles for article (PubMed ID: 22088602)
1. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1: diffusion weighted imaging findings of brain.
Alkan A; Sigirci A; Kutlu R; Ozcan H; Erdem G; Aslan M; Ates O; Yakinci C; Egri M
Eur J Radiol; 2005 Nov; 56(2):229-34. PubMed ID: 15963674
[TBL] [Abstract][Full Text] [Related]
3. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.
Ferraz-Filho JR; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Pediatr Radiol; 2012 Apr; 42(4):449-54. PubMed ID: 22033857
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.
Billiet T; Mädler B; D'Arco F; Peeters R; Deprez S; Plasschaert E; Leemans A; Zhang H; den Bergh BV; Vandenbulcke M; Legius E; Sunaert S; Emsell L
Neuroimage Clin; 2014; 4():649-58. PubMed ID: 24936416
[TBL] [Abstract][Full Text] [Related]
5. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
[TBL] [Abstract][Full Text] [Related]
6. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
DeBella K; Poskitt K; Szudek J; Friedman JM
Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
[TBL] [Abstract][Full Text] [Related]
7. Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1.
Tognini G; Ferrozzi F; Garlaschi G; Piazza P; Patti A; Virdis R; Bertolino C; Bertolino G; Manfredini D; Zompatori M; Crisi G
J Comput Assist Tomogr; 2005; 29(3):298-304. PubMed ID: 15891494
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the basal ganglia in neurofibromatosis type 1.
Nicita F; Di Biasi C; Sollaku S; Cecchini S; Salpietro V; Pittalis A; Papetti L; Ursitti F; Ulgiati F; Zicari AM; Gualdi GF; Properzi E; Duse M; Ruggieri M; Spalice A
Childs Nerv Syst; 2014 Feb; 30(2):319-25. PubMed ID: 23892392
[TBL] [Abstract][Full Text] [Related]
9. Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1.
Lopes Ferraz Filho JR; Munis MP; Soares Souza A; Sanches RA; Goloni-Bertollo EM; Pavarino-Bertelli EC
Pediatr Radiol; 2008 Mar; 38(3):305-10. PubMed ID: 18231788
[TBL] [Abstract][Full Text] [Related]
10. Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects.
Hervey-Jumper SL; Singla N; Gebarski SS; Robertson P; Maher CO
Pediatr Neurosurg; 2013; 49(1):55-9. PubMed ID: 24192157
[TBL] [Abstract][Full Text] [Related]
11. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
[TBL] [Abstract][Full Text] [Related]
12. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images.
Fu JL; Zhang T; Chang C; Zhang YZ; Li WB
Acta Radiol; 2012 Apr; 53(3):312-7. PubMed ID: 22416261
[TBL] [Abstract][Full Text] [Related]
13. The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis.
Di Stasi M; Cocozza S; Buccino S; Paolella C; Di Napoli L; D'Amico A; Melis D; Ugga L; Villano G; Ruocco M; Scala I; Brunetti A; Elefante A
Acta Neurol Belg; 2024 Feb; 124(1):223-230. PubMed ID: 37733157
[TBL] [Abstract][Full Text] [Related]
14. [Unidentified bright objects and neuropsychiatric disturbances].
Bassi B; Vannelli S; Giraudo MC; Burdino E; Rigardetto R
Minerva Pediatr; 2013 Aug; 65(4):371-81. PubMed ID: 24051970
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the detectability of UBOs in Neurofibromatosis Type I patients with proton density-weighted and FLAIR sequences in 3T MRI.
Tritt S; Hillenbrand N; Liesirova K; Moein G; Kieslich M; Porto L
Eur J Paediatr Neurol; 2018 Jul; 22(4):615-619. PubMed ID: 29610060
[TBL] [Abstract][Full Text] [Related]
16. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
[TBL] [Abstract][Full Text] [Related]
17. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
[TBL] [Abstract][Full Text] [Related]
19. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
20. Microstructural and volumetric abnormalities of the putamen in juvenile myoclonic epilepsy.
Keller SS; Ahrens T; Mohammadi S; Möddel G; Kugel H; Ringelstein EB; Deppe M
Epilepsia; 2011 Sep; 52(9):1715-24. PubMed ID: 21635242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
